Heart failure startup CardioKinetix gets $50M in round led by Edwards Lifesciences
Heart failure device startup CardioKinetix should have ample funding to wrap up a pivotal clinical trial that’ll allow it to receive pre-market approval from the FDA: It just raised $50 million in financing, led by Edwards Lifesciences Corp. – which also scooped up exclusive rights to acquire CardioKinetix based on future regulatory milestones. Menlo Park-based CardioKinetix has […]